Stressful life events and insomnia may increase risk of atrial fibrillation in postmenopausal women

After menopause an estimated 1 in 4 women may develop irregular heart rhythms -; known as atrial fibrillation – in their lifetime, with stressful life events and insomnia being major contributing factors, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

FDA grants priority review for Neurocrine’s crinecerfont NDAs

The asset is intended to treat congenital adrenal hyperplasia in paediatric and adult patients. Credit: YURIMA / Shutterstock. The US Food and Drug Administration (FDA)

July 2, 2024

Top 10 Psychedelic Companies That Should Be on Your Radar | Psychedelic Invest

The psychedelic industry is changing and growing rapidly. Psychedelic medicines are being catapulted into the mainstream, and these top 10 psychedelic companies are the companies

August 24, 2023

Gilead and MSD to advance once-weekly HIV treatment to Phase III – Pharmaceutical Technology

The treatment combines MSD’s islatravir with Gilead’s lenacapavir. Credit: Ground Picture via Shutterstock. Gilead Sciences and MSD are advancing their once-weekly HIV treatment regimen to

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.